Literature DB >> 24963125

Intracranial pressure in hydrocephalus: impact of shunt adjustments and body positions.

Dan Farahmand1, Sara Qvarlander2, Jan Malm3, Carsten Wikkelsö1, Anders Eklund2, Magnus Tisell1.   

Abstract

BACKGROUND: The association between intracranial pressure (ICP) and different shunt valve opening pressures in relation to body positions is fundamental for understanding the physiological function of the shunt.
OBJECTIVE: To analyse the ICP and ICP wave amplitude (AMP) at different shunt settings and body positions in patients with hydrocephalus.
METHODS: In this prospective study 15 patients with communicating hydrocephalus were implanted with a ligated adjustable ventriculoperitoneal shunt. They also received a portable intraparenchymatous ICP-monitoring device. Postoperative ICP and AMP were recorded with the patients in three different body positions (supine, sitting and walking) and with the shunt ligated and open at high, medium and low valve settings. In each patient 12 10 min segments were coded, blinded and analysed for mean ICP and mean AMP using an automated computer algorithm.
RESULTS: Mean ICP and mean AMP were lower at all three valve settings compared with the ligated shunt state (p<0.001). Overall, when compared with the supine position, mean ICP was 11.5±1.1 (mean±SD) mm Hg lower when sitting and 10.5±1.1 mm Hg lower when walking (p<0.001). Mean ICP was overall 1.1 mm Hg higher (p=0.042) when walking compared with sitting. The maximal adjustability difference (highest vs lowest valve setting) was 4.4 mm Hg.
CONCLUSIONS: Changing from a supine to an upright position reduced ICP while AMP only increased at trend level. Lowering of the shunt valve opening pressure decreased ICP and AMP but the difference in mean ICP in vivo between the highest and lowest opening pressures was less than half that previously observed in vitro. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Dementia; Neuropsychology; Neurosurgery; Physiology

Mesh:

Year:  2014        PMID: 24963125     DOI: 10.1136/jnnp-2014-307873

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  Ventricular Volume Is More Strongly Associated with Clinical Improvement Than the Evans Index after Shunting in Idiopathic Normal Pressure Hydrocephalus.

Authors:  J Neikter; S Agerskov; P Hellström; M Tullberg; G Starck; D Ziegelitz; D Farahmand
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-11       Impact factor: 3.825

Review 2.  Telemetric Intracranial Pressure Monitoring: A Systematic Review.

Authors:  Mahmoud Omidbeigi; Monireh-Sadat Mousavi; Sogol Meknatkhah; Maryam Edalatfar; Ausaf Bari; Mahdi Sharif-Alhoseini
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

3.  Can intracranial pressure be measured non-invasively bedside using a two-depth Doppler-technique?

Authors:  Lars-Owe D Koskinen; Jan Malm; Rolandas Zakelis; Laimonas Bartusis; Arminas Ragauskas; Anders Eklund
Journal:  J Clin Monit Comput       Date:  2016-03-14       Impact factor: 2.502

4.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.

Authors:  Madoka Nakajima; Shigeki Yamada; Masakazu Miyajima; Kazunari Ishii; Nagato Kuriyama; Hiroaki Kazui; Hideki Kanemoto; Takashi Suehiro; Kenji Yoshiyama; Masahiro Kameda; Yoshinaga Kajimoto; Mitsuhito Mase; Hisayuki Murai; Daisuke Kita; Teruo Kimura; Naoyuki Samejima; Takahiko Tokuda; Mitsunobu Kaijima; Chihiro Akiba; Kaito Kawamura; Masamichi Atsuchi; Yoshihumi Hirata; Mitsunori Matsumae; Makoto Sasaki; Fumio Yamashita; Shigeki Aoki; Ryusuke Irie; Hiroji Miyake; Takeo Kato; Etsuro Mori; Masatsune Ishikawa; Isao Date; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-01-15       Impact factor: 1.742

5.  Brain MRI and Ophthalmic Biomarkers of Intracranial Pressure.

Authors:  Linda D'Antona; Hasan Asif; Claudia Louise Craven; James Alexander McHugh; Anna Vassiliou; Lewis Thorne; Manjit Singh Matharu; Laurence Dale Watkins; Fion Bremner; Ahmed Kassem Toma
Journal:  Neurology       Date:  2021-04-13       Impact factor: 11.800

6.  Human jugular vein collapse in the upright posture: implications for postural intracranial pressure regulation.

Authors:  Petter Holmlund; Elias Johansson; Sara Qvarlander; Anders Wåhlin; Khalid Ambarki; Lars-Owe D Koskinen; Jan Malm; Anders Eklund
Journal:  Fluids Barriers CNS       Date:  2017-06-17

7.  FSI simulation of CSF hydrodynamic changes in a large population of non-communicating hydrocephalus patients during treatment process with regard to their clinical symptoms.

Authors:  Seifollah Gholampour
Journal:  PLoS One       Date:  2018-04-30       Impact factor: 3.240

8.  Paradoxical response of intracranial pressure to shunt valve setting adjustments.

Authors:  Linda D'Antona; Claudia Louise Craven; Melida Andrea Jaime Merchan; Simon David Thompson; Fion Bremner; Lewis Thorne; Manjit Singh Matharu; Laurence Dale Watkins; Ahmed Kassem Toma
Journal:  Acta Neurochir (Wien)       Date:  2020-06-24       Impact factor: 2.216

9.  Lumboperitoneal Shunts for the Treatment of Idiopathic Normal Pressure Hydrocephalus: A Comparison of Small-Lumen Abdominal Catheters to Gravitational Add-On Valves in a Single Center.

Authors:  Madoka Nakajima; Masakazu Miyajima; Chihiro Akiba; Ikuko Ogino; Kaito Kawamura; Hidenori Sugano; Takeshi Hara; Yuichi Tange; Keiko Fusegi; Kostadin Karagiozov; Hajime Arai
Journal:  Oper Neurosurg (Hagerstown)       Date:  2018-12-01       Impact factor: 2.703

10.  Cerebrospinal fluid micro-volume changes inside the spinal space affect intracranial pressure in different body positions of animals and phantom.

Authors:  Marijan Klarica; Milan Radoš; Gorislav Erceg; Ivana Jurjević; Antonio Petošić; Zdravko Virag; Darko Orešković
Journal:  Front Mol Neurosci       Date:  2022-09-14       Impact factor: 6.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.